| Literature DB >> 24881074 |
Vincent Cottin1, Bruno Crestani2, Dominique Valeyre2, Benoit Wallaert2, Jacques Cadranel2, Jean-Charles Dalphin2, Philippe Delaval2, Dominique Israel-Biet2, Romain Kessler2, Martine Reynaud-Gaubert2, Bernard Aguilaniu2, Benoit Bouquillon2, Philippe Carré2, Claire Danel2, Jean-Baptiste Faivre2, Gilbert Ferretti2, Nicolas Just2, Serge Kouzan2, François Lebargy2, Sylvain Marchand-Adam2, Bruno Philippe2, Grégoire Prévot2, Bruno Stach2, Françoise Thivolet-Béjui2, Jean-François Cordier2.
Abstract
Idiopathic pulmonary fibrosis (IPF) is the most frequent chronic idiopathic interstitial pneumonia in adults. The management of rare diseases in France has been organised by a national plan for rare diseases, which endorsed a network of expert centres for rare diseases throughout France. This article is an overview of the executive summary of the French guidelines for the management of IPF, an initiative that emanated from the French National Reference Centre and the Network of Regional Competence Centres for Rare Lung Diseases. This review aims at providing pulmonologists with a document that: 1) combines the current available evidence; 2) reviews practical modalities of diagnosis and management of IPF; and 3) is adapted to everyday medical practice. The French practical guidelines result from the combined efforts of a coordination committee, a writing committee and a multidisciplinary review panel, following recommendations from the Haute Autorité de Santé. All recommendations included in this article received at least 90% agreement by the reviewing panel. Herein, we summarise the main conclusions and practical recommendations of the French guidelines. ©ERS 2014.Entities:
Mesh:
Year: 2014 PMID: 24881074 DOI: 10.1183/09059180.00001814
Source DB: PubMed Journal: Eur Respir Rev ISSN: 0905-9180